
    
      This study aims as primary objective to evaluate short and long term pain relief following
      the administration of radiosurgery to the celiac plexus in patients with upper abdominal
      cancer. As secondary objectives it will describe acute and late side effects and quality of
      life measures of patients undergoing the treatment.

      The study has a prospective, single arm design. It will be composed from an initial run-in
      safety assessment that will include 6 patients and then continue as a phase II trial. All
      eligible patients will receive the same protocol of celiac plexus radiosurgery and will be
      evaluated before, during and following this treatment.

      The treatment duration is one and a half weeks (5 fractions delivered every other weekday).
    
  